Injuries and osteoarthritis of the knee are common. Fortunately, there are many ways to prevent and treat knee pain.

Knee injuries are common in athletes, accounting for 41% of all athletic injuries . But knee injuries aren't limited to competitive athletes. In our ...

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

BioSciences announced new data demonstrating its gene therapy for osteoarthritis candidate, PCRX-201, provided sustained ...

The weight-loss jab Wegovy made its debut on June 4 2021 . It was the first new weight-loss drug to be approved by the US ...

Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

Prof Conor Buckley discusses his biomaterials research and how community engagement can make the public feel ‘empowered’ by ...

Winter often worsens joint pain, especially for arthritis sufferers. Experts share tips for managing cold-related joint stiffness. Their key advice includes staying active, keeping joints warm, ...

The weight-loss jab Wegovy made its debut on June 4 2021 . It was the first new weight-loss drug to be approved by the US Food and Drug ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.